Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 1
Results: 21
Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 215, doi. 10.1007/s00262-020-02677-7
- By:
- Publication type:
- Article
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 253, doi. 10.1007/s00262-020-02675-9
- By:
- Publication type:
- Article
Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 245, doi. 10.1007/s00262-020-02673-x
- By:
- Publication type:
- Article
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 233, doi. 10.1007/s00262-020-02672-y
- By:
- Publication type:
- Article
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 169, doi. 10.1007/s00262-020-02671-z
- By:
- Publication type:
- Article
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 189, doi. 10.1007/s00262-020-02669-7
- By:
- Publication type:
- Article
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 137, doi. 10.1007/s00262-020-02668-8
- By:
- Publication type:
- Article
Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 177, doi. 10.1007/s00262-020-02667-9
- By:
- Publication type:
- Article
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 153, doi. 10.1007/s00262-020-02666-w
- By:
- Publication type:
- Article
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 107, doi. 10.1007/s00262-020-02665-x
- By:
- Publication type:
- Article
Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 89, doi. 10.1007/s00262-020-02663-z
- By:
- Publication type:
- Article
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 101, doi. 10.1007/s00262-020-02662-0
- By:
- Publication type:
- Article
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 203, doi. 10.1007/s00262-020-02660-2
- By:
- Publication type:
- Article
Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 123, doi. 10.1007/s00262-020-02659-9
- By:
- Publication type:
- Article
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 47, doi. 10.1007/s00262-020-02657-x
- By:
- Publication type:
- Article
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 75, doi. 10.1007/s00262-020-02656-y
- By:
- Publication type:
- Article
Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 19, doi. 10.1007/s00262-020-02655-z
- By:
- Publication type:
- Article
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 31, doi. 10.1007/s00262-020-02654-0
- By:
- Publication type:
- Article
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 61, doi. 10.1007/s00262-020-02653-1
- By:
- Publication type:
- Article
Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 1, doi. 10.1007/s00262-020-02649-x
- By:
- Publication type:
- Article
Patterns of progression in patients treated for immuno-oncology antibodies combination.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 221, doi. 10.1007/s00262-020-02647-z
- By:
- Publication type:
- Article